Abstract:Vascular calcification (VC) has emerged as a key predictor of cardiovascular events in patients with chronic kidney disease (CKD). In recent years, an expanding body of research has put forth the concept of accelerated vascular aging among CKD patients, highlighting the significance of vascular cells senescence in the process of VC. Within the milieu of uremia, senescent vascular endothelial cells (VECs) release extracellular microvesicles (MV) that promote vascular smooth muscle cells (VSMCs) senescence, thereby triggering the subsequent osteogenic phenotypic switch and ultimately contributing to the VC process. In addition, senescent vascular progenitor or stem cells with diminished ability to differentiate into VECs and VSMCS, compromise the repair of vascular integrity, on the other hand, release a cascade of molecules associated with senescence, collectively known as the senescence-associated secretory phenotype (SASP), perpetuating the senescence phenomenon. Furthermore, SASP triggers the recruitment of monocytes and macrophages, as well as adjacent VECs and VSMCs into a pro-adhesive and pro-inflammatory senescent state. This pro-inflammatory microenvironment niche not only impacts the functionality of immune cells but also influences the differentiation of myeloid immune cells, thereby amplifying the reduced ability to effectively clear senescent cells of senescent macrophages, promoted calcification of VSMCs. The objective of this paper is to provide a comprehensive review of the contribution of vascular cell senescence to the emergence and advancement of VC. Gaining a comprehensive understanding of the involvement of cellular senescence within the vessel wall is pivotal, especially when it comes to its intersection with VC. This knowledge is essential for advancing groundbreaking anti-aging therapies, aiming to effectively mitigate cardiovascular diseases.

Vascular calcification in CKD: New insights into its mechanisms

The Role of Extracellular Vesicles in Vascular Calcification in Chronic Kidney Disease

Advances in the mechanisms of vascular calcification in chronic kidney disease

Current Understanding of Cardiovascular Calcification in Patients with Chronic Kidney Disease

Role of crosstalk between endothelial cells and smooth muscle cells in vascular calcification in chronic kidney disease

The pathophysiology and management of vascular calcification in chronic kidney disease patients

Vascular Calcification in Chronic Kidney Disease: An Update and Perspective

Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches

Mitochondria and vascular calcification in chronic kidney disease: Lessons learned from the past to improve future therapy

Vascular calcification: Molecular mechanisms and therapeutic interventions

The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts

Role of Mitochondrial Dysfunction in CKD-related Vascular Calcification: From Mechanisms to Therapeutics

Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification

Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects

Vascular Calcification in Chronic Kidney Disease is Induced by Bone Morphogenetic Protein-2 Via a Mechanism Involving the Wnt/β-Catenin Pathway

Vascular Calcification—New Insights into Its Mechanism

Vascular Calcification is Associated with Wnt-signaling Pathway and Blood Pressure Variability in Chronic Kidney Disease Rats.

Altered serum metabolome associated with vascular calcification developed from CKD and the critical pathways

The functional role of cellular senescence during vascular calcification in chronic kidney disease

[The Mechanisms of High-Phosphate-induced Vascular Calcification in Patients with Chronic Kidney Disease].

The role and mechanism of protein post‑translational modification in vascular calcification (Review)